Terms: = Germ cell tumor AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R AND Clinical Outcome
2 results:
1. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?
Gandhi P; Khare R; Garg N; Mishra J
J Cancer Res Ther; 2022; 18(1):224-230. PubMed ID: 35381788
[TBL] [Abstract] [Full Text] [Related]
2. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes.
Maraveyas A; Baban B; Kennard D; Rook GA; Westby M; Grange JM; Lydyard P; Stanford JL; Jones M; Selby P; Dalgleish AG
Ann Oncol; 1999 Jul; 10(7):817-24. PubMed ID: 10470429
[TBL] [Abstract] [Full Text] [Related]
